Sponsor

Clinical trials sponsored by Pfizer

Active studies whose public registry record names Pfizer as lead sponsor.

12active studies

3recruiting now

11countries represented

188largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Obesity, Overweight and/or ObesityCondition

PF-08653944, PlaceboTreatment

Brazil, Canada50 locations

PfizerSponsor

Updated 2026-09-04 · NCT07595549See eligibility →

Recruiting nowPhase 2

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

Overweight, ObesityCondition

PF-08653945, PF-08653944Treatment

Canada, United States65 locations

PfizerSponsor

Updated 2026-08-17 · NCT07575932See eligibility →

Recruiting nowPhase 1, Phase 2

A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

Obesity and Obesity-related Medical ConditionsCondition

MET233 and MET097, PlaceboTreatment

United States1 locations

PfizerSponsor

Updated 2026-06-01 · NCT06924320See eligibility →

Opening soonPhase 3

A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity

Obesity, OverweightCondition

Berobenatide, PlaceboTreatment

China33 locations

PfizerSponsor

Updated 2026-09-04 · NCT07792954See eligibility →

Opening soonPhase 3

A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)

ObesityCondition

Berobenatide, PlaceboTreatment

Japan12 locations

PfizerSponsor

Updated 2026-09-04 · NCT07794761See eligibility →

Opening soonPhase 3

A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)

ObesityCondition

Berobenatide, PlaceboTreatment

Japan11 locations

PfizerSponsor

Updated 2026-09-04 · NCT07794774See eligibility →

Opening soonPhase 1

A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity

ObesityCondition

PF-08642534, PlaceboTreatment

United States1 locations

PfizerSponsor

Updated 2026-07-28 · NCT07731139See eligibility →

Opening soonPhase 1

A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity

Overweight, ObesityCondition

PF-08653945Treatment

Belgium1 locations

PfizerSponsor

Updated 2026-07-24 · NCT07725809See eligibility →

Active, not recruitingPhase 3

A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

Obesity, Overweight and/or ObesityCondition

PF-08653944, PlaceboTreatment

Argentina, Bulgaria188 locations

PfizerSponsor

Updated 2026-09-08 · NCT07400653See eligibility →

Active, not recruitingPhase 3

Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

Obesity and OverweightCondition

MET097, PlaceboTreatment

Bulgaria, Canada169 locations

PfizerSponsor

Updated 2026-09-04 · NCT07311850See eligibility →

Active, not recruitingPhase 1

A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity

Obesity, Overweight and/or ObesityCondition

PF-08653944, AcetaminophenTreatment

United States1 locations

PfizerSponsor

Updated 2026-07-09 · NCT07508241See eligibility →

Active, not recruitingPhase 2

A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight

Obesity, Overweight or ObesityCondition

MET097, PlaceboTreatment

United States5 locations

PfizerSponsor

Updated 2026-05-29 · NCT06973720See eligibility →

Related sponsors

Novo Nordisk A/S71 Eli Lilly and Company67 University of Colorado, Denver36 Cairo University31 Mayo Clinic29 Norwegian University of Science and Technology25

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.